[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100420885":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":24,"locations":31,"responsibleParty":45,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":52,"sex":53,"minAge":54,"maxAge":10,"enrollmentInfo":55,"targetDuration":58,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":10,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"National Taiwan University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Case group",null,"HIV infected men who have sex with men",[13],"Diagnostic Test: Testosterone",{"label":15,"type":10,"description":16,"interventionNames":17},"Control group","HIV non-infected men",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DIAGNOSTIC_TEST","Testosterone","Serum total testosterone and free testosterone level",[9,15],[25],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},"Shyang-Rong Shih, Ph.D.","CONTACT","+886-2-2312-3456","61613","srshih@ntu.edu.tw",[32],{"facility":5,"status":33,"city":34,"state":10,"zip":35,"country":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"RECRUITING","Taipei","100","Taiwan",{"type":38,"coordinates":39},"Point",[40,41],121.52639,25.05306,{"lat":41,"lon":40},[44],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100420885",false,"NCT04760574","Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism","Inclusion Criteria:\n\n* HIV-infected men who have sex with men\n* HIV non-infected men\n\nExclusion Criteria:\n\n* Use of testosterone supplement, anabolic steroid in the past one year.\n* History of pituitary , adrenal or gonad diseases\n* History of pituitary surgery or radiation therapy\n* History of systemic chemotherapy\n* Active opportunistic infection under treatment\n* Cancer\n* Severe hepatic, renal or cardiac impairment",true,"MALE","20 Years",{"count":56,"type":57},1200,"ESTIMATED","10 Years","OBSERVATIONAL","Cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population",[62],"Hypogonadism; Ovarian","2021-03-01",{"date":65,"type":66},"2021-03-03","ACTUAL",{"date":68,"type":66},"2021-02-02",{"date":70,"type":57},"2030-11",{"name":5,"class":6},1]